AI Meets Obesity Drugs: Generate Biomedicines and Zealand Pharma Ink Up to $1.2 Billion Protein Therapeutics Deal

Generate Biomedicines receives $30M upfront in a deal with Zealand Pharma to advance AI protein candidates for obesity, up to $1.2B total.